Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-03-21

Clinical Trial Update: Predict to Prevent PGRN Disease [NA]

View source ↗

Summary

A clinical trial investigating GRN-related frontotemporal dementia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Frontotemporal Dementia (FTD), GRN Related Frontotemporal Dementia | NA | Status: WITHDRAWN